经鼻高流量氧疗调节经口插管患者呼吸困难
该研究在20例经口插管行压力支持通气且呼吸困难数字评分(NRS)>3分的患者中,比较了有无经鼻高流量(NHF;FiO2 21%;温度31°C)时的呼吸困难、气道闭合压(P0.1)和吸气做功。压力支持通气期间,NHF 0 L/min时呼吸困难NRS为5(范围4-6),NHF 30 L/min和50 L/min时分别为3(范围2-6)和3(范围2-5),差异有统计学意义(P<0.05),但MV-RDOS评分、P0.1、食管压、呼吸肌肌电和血气无变化。自主呼吸试验期间,NHF 50 L/min时呼吸困难NRS和P0.1低于NHF 0 L/min(P<0.01和P=0.04),MV-RDOS评分、食管压和呼吸肌肌电无变化。结论认为,经口插管患者NHF与较低呼吸困难和较低呼吸驱动相关,但不影响吸气做功。
要点
- 压力支持通气期间,NHF 0 L/min时呼吸困难NRS为5(范围4-6),NHF 30 L/min和50 L/min时均为3(范围2-6和2-5),P<0.05。
- 自主呼吸试验期间,NHF 50 L/min时呼吸困难NRS低于NHF 0 L/min(P<0.01)。
- 自主呼吸试验期间,NHF 50 L/min时P0.1低于NHF 0 L/min(P=0.04)。
- 压力支持通气期间,NHF 30和50 L/min时MV-RDOS评分、P0.1、食管压、呼吸肌肌电和血气较NHF 0 L/min无变化。
- 自主呼吸试验期间,NHF 50 L/min时MV-RDOS评分、食管压和呼吸肌肌电较NHF 0 L/min无变化。
适用人群与场景
- 经口插管、行压力支持通气、呼吸困难NRS评分>3分的成人患者。
诊断标准与关键阈值
- 呼吸困难采用数字评分量表(NRS)和机械通气-呼吸窘迫观察量表(MV-RDOS)评估。
- 入组条件为压力支持通气期间呼吸困难NRS评分>3分。
处置流程与药物剂量
- 压力支持通气期间,依次给予NHF 0 L/min,随后30、50和60 L/min(后三个流量随机顺序),NHF设置FiO2 21%、温度31°C。
- 自主呼吸试验期间,随机给予NHF 0 L/min或50 L/min。
研究设计与关键结果
- 研究类型为在经口插管行压力支持通气的患者中进行的生理学比较研究,纳入20例。
- 压力支持通气期间,NHF 0 L/min时呼吸困难NRS为5(范围4-6),NHF 30 L/min时为3(范围2-6),NHF 50 L/min时为3(范围2-5),与NHF 0 L/min相比P<0.05。
- 压力支持通气期间,NHF 30和50 L/min时MV-RDOS评分、P0.1、食管压、呼吸肌肌电和血气较NHF 0 L/min无变化。
- 自主呼吸试验期间,NHF 50 L/min时呼吸困难NRS低于NHF 0 L/min(P<0.01)。
- 自主呼吸试验期间,NHF 50 L/min时P0.1低于NHF 0 L/min(P=0.04)。
- 自主呼吸试验期间,NHF 50 L/min时MV-RDOS评分、食管压和呼吸肌肌电较NHF 0 L/min无变化。
证据类型、等级与局限
- 证据类型:在经口插管患者中进行的生理学比较研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 经口插管行压力支持通气且呼吸困难NRS>3分的患者,NHF 30和50 L/min与呼吸困难NRS降低相关(P<0.05),但MV-RDOS评分、P0.1、食管压、呼吸肌肌电和血气无变化。
- 经口插管患者自主呼吸试验期间,NHF 50 L/min与呼吸困难NRS和P0.1降低相关(P<0.01和P=0.04),但MV-RDOS评分、食管压和呼吸肌肌电无变化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: High-flow therapy reduces dyspnea in acute respiratory failure, but the underlying mechanisms are not fully elucidated. Objectives: To compare dyspnea, we measured airway occlusion pressure (P0.1) and inspiratory work with and without nasal high flow (NHF; FiO2, 21%; temperature, 31°C) in intubated patients under pressure support ventilation and during a spontaneous breathing trial (SBT). Methods: Dyspnea (determined using numerical rating scale [NRS] and Mechanical Ventilation - Respiratory Distress Observational Scale [MV-RDOS] scores), P0.1, esophageal pressure, respiratory muscle EMG, and arterial blood gas were compared in intubated patients on pressure support ventilation presenting a dyspnea-NRS score higher than 3 during two sequences: 1) pressure support ventilation with NHF at 0 L/min followed by 30, 50, and 60 L/min (the last three were randomized) and 2) an SBT with NHF at 0 and 50 L/min (randomized). Measurements and Main Results: Twenty patients were included. During pressure support ventilation, as compared with a dyspnea-NRS score of 5 (range = 4-6) at an NHF of 0 L/min, dyspnea-NRS scores were 3 (range = 2-6) and 3 (range = 2-5) at NHFs of 30 L/min and 50 L/min, respectively (P < 0.05). However, there was no change in MV-RDOS score, P0.1, esophageal pressure, respiratory muscle EMG, and gas exchange. During the SBT, at an NHF of 50 L/min, dyspnea-NRS score and P0.1 were lower than during the SBT at an NHF of 0 L/min (P < 0.01 and P = 0.04, respectively), whereas MV-RDOS score, esophageal pressure, and respiratory muscle EMG did not change as compared with findings in an SBT with an NHF of 0 L/min. Conclusions: In orally intubated patients, NHF was associated with lower dyspnea and lower respiratory drive without affecting the inspiratory work.
参考来源
- Le Stang V, Graverot M, Kimmoun A, et al. Nasal High Flow to Modulate Dyspnea in Orally Intubated Patients. Am J Respir Crit Care Med. 2025. PMID: 39680951. doi:10.1164/rccm.202405-1057OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。